|View printer-friendly version|
|Array CEO Robert E. Conway to Speak at the Third Annual Needham Biotechnology Conference|
BOULDER, Colo., June 9 /PRNewswire-FirstCall/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the Needham Biotechnology Conference on June 17 in New York City. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
Event: Third Annual Needham Biotechnology Conference Presenter: Robert E. Conway, Chief Executive Officer, Array BioPharma Date: Thursday, June 17, 2004 Time: 10:00 a.m. Eastern Time Location: The New York Palace Hotel, New York City Webcast: www.arraybiopharma.com
About Array BioPharma:
Array BioPharma is creating the next generation of orally active drugs by integrating the latest advances in chemistry, biology and informatics. Our drug development pipeline is focused primarily in cancer and inflammatory disease and includes several promising small molecule drugs that regulate targets in therapeutically important disease pathways. In addition, Array collaborates with leading pharmaceutical and biotechnology companies to design, create and optimize drug candidates across a broad range of therapeutic areas. Our mission is to be the most efficient inventor of high quality drug candidates in the pharmaceutical industry. For more information on Array, please go to www.arraybiopharma.com.